Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial | |
Xu, Bo; Yang, Yuejin; Han, Yaling; Huo, Yong; Wang, Lefeng; Qi, Xiangqian; Li, Jifu; Chen, Yundai; Kuo, Hai-Chien; Ying, Shih-Wa | |
2018 | |
卷号 | 14期号:5页码:554-561 |
关键词 | bioresorbable scaffolds clinical research clinical trials |
ISSN号 | 1774-024X |
DOI | 10.4244/EIJ-D-17-00796 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6355102 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Bo,Yang, Yuejin,Han, Yaling,et al. Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial[J],2018,14(5):554-561. |
APA | Xu, Bo.,Yang, Yuejin.,Han, Yaling.,Huo, Yong.,Wang, Lefeng.,...&Stone, Gregg W..(2018).Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial.,14(5),554-561. |
MLA | Xu, Bo,et al."Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial".14.5(2018):554-561. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论